| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/03/2008 | EP1996215A2 Metabolic regulators and uses thereof |
| 12/03/2008 | EP1996211A1 Gallium compositions for the treatment of liver cancer and methods of use |
| 12/03/2008 | EP1996183A1 Method of treatment or prophylaxis inflammatory pain |
| 12/03/2008 | EP1996162A2 Methods and compositions for treatment of diastolic heart failure |
| 12/03/2008 | EP1641818B1 Polypeptides having binding affinity for her2 |
| 12/03/2008 | EP1575354B1 Melusin, a muscle specific protein, as a drug target for prevention and treatment of heart failure, and applications thereof |
| 12/03/2008 | EP1470144B1 Oligonucleotides comprising alternating segments and uses thereof |
| 12/03/2008 | EP1437365B1 Use of cardiotrophin in hepatic diseases |
| 12/03/2008 | EP1419129B1 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 12/03/2008 | EP1397106B1 Dental restorative materials |
| 12/03/2008 | EP1352665B1 Method for surface treatment of implants or prosthesis made of titanium |
| 12/03/2008 | EP1320591B1 Atcr-1, a human acyltransferase and uses thereof |
| 12/03/2008 | EP1303293B1 Sequential administration of cpt-11 and apo-2l polypeptide |
| 12/03/2008 | EP1204677B1 Cyclohexapeptide compounds, process for their production and their use as a pharmaceutical |
| 12/03/2008 | EP1121140B1 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 12/03/2008 | EP1097233B1 Growth differentiation factor promoter and uses therefor |
| 12/03/2008 | EP1043395B1 Novel g protein-coupled receptor proteins |
| 12/03/2008 | EP1006122B1 Phenethylamine derivatives |
| 12/03/2008 | EP0812208B1 Pharmaceutical compositions for controlled release of soluble receptors |
| 12/03/2008 | EP0606217B2 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 12/03/2008 | CN101316859A Aryiialkyl and heteroarylalkyl derivatives of cyclosporine A for the treatment and prevention of viral infection |
| 12/03/2008 | CN101316614A Kit for parenteral administration of medicaments |
| 12/03/2008 | CN101316607A PDGF amphiphilic polymer complex |
| 12/03/2008 | CN101316606A Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection |
| 12/03/2008 | CN101316605A Novel use of ubiquitin c-terminal hydrolase-l1 |
| 12/03/2008 | CN101316604A Inhibitors of inflammatory cytokine transcription derived from hcmv protein IE2 |
| 12/03/2008 | CN101316576A A composition comprising a coupled enzyme system |
| 12/03/2008 | CN101314794A Method for detecting oral squamous-cell carcinoma and method for suppressing the same |
| 12/03/2008 | CN101314793A Method for detecting ovarian cancer and method for suppresssing the same |
| 12/03/2008 | CN101314775A RNA disturbance target point capable of being used for treating AIDS |
| 12/03/2008 | CN101314769A Staphylokinase and expression vector thereof |
| 12/03/2008 | CN101314617A Novel snake venom polypeptide, preparation and application thereof |
| 12/03/2008 | CN101314616A Hemorrhagic bacillus coli of intestine 0157:H7 shiga toxin IIB epitope peptide and uses thereof |
| 12/03/2008 | CN101314034A Recombined nattokinase oral preparation, preparation method and application thereof |
| 12/03/2008 | CN101314033A Oral liquid synergistic agent for livestock, poultry and aquatic product, and preparation method thereof |
| 12/03/2008 | CN101314032A Preparation technique for specified transfer factor oral preparation for typhoid fever, paratyphoid fever |
| 12/03/2008 | CN101314031A Preparation for improving osteotrophy |
| 12/03/2008 | CN101314030A Preparation for accelerating bone growth |
| 12/03/2008 | CN101314029A Acetylsalicylic peptide and preparation method thereof |
| 12/03/2008 | CN101314028A Plumbum capsule and pill of AD calcium line |
| 12/03/2008 | CN101314027A Sea backthern lysine particle |
| 12/03/2008 | CN101314026A Serositis in duckling vaccine oral liquid synergistic agent for poultry biology and preparation method thereof |
| 12/03/2008 | CN101314025A Anti-inflammation febrifuge medicament and preparation method thereof |
| 12/03/2008 | CN101314024A Traditional Chinese medicine capsule for treating AIDS |
| 12/03/2008 | CN100439499C Neutrokine-alpha and Neutrokine-alpha splice variant |
| 12/03/2008 | CN100439400C Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 12/03/2008 | CN100439397C Crystallization of IGF-1 |
| 12/03/2008 | CN100439396C Polypeptide of ramification of ciliary nerves nutrilite for curing obesity |
| 12/03/2008 | CN100439395C Compositions and methods for therapy and diagnosis of ovarian cancer |
| 12/03/2008 | CN100439394C Pharmaceutical use for secreted bacterial effector proteins |
| 12/03/2008 | CN100439393C Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 12/03/2008 | CN100439392C Novel method for the synthesis of perinidopril and the pharmaceutically acceptable salts thereof |
| 12/03/2008 | CN100438912C Self-assembled luminous current-conducting nano medicine crystal and ultra-thin film and preparation method thereof |
| 12/03/2008 | CN100438906C The use of copolymer 1 and related peptides and polypeptides and T cell treated therewith for neuroprotective therapy |
| 12/03/2008 | CN100438905C Stable liquid formulations of botulinum toxin |
| 12/03/2008 | CN100438870C Method for treating diseases with omega interferon |
| 12/03/2008 | CN100438857C Solid dosage form comprising desmopressin and method for manufacturing thereof |
| 12/02/2008 | US7459601 Animal model for use in monitoring aggregation of alpha -synuclein non-amyloid component (NAC) and identifying agent for treatment of nervous system disorders; neuroprotective agents |
| 12/02/2008 | US7459600 Isolation, selection and propagation of animal transgenic stem cells |
| 12/02/2008 | US7459544 Comprises nucleotide sequences coding b lymphocyte antigens for use as tool in prevention and treatment of cell proliferative disorders; immunotherapy |
| 12/02/2008 | US7459543 Modulators of antiestrogen pharmacology |
| 12/02/2008 | US7459541 Fusion polypeptide comprising a collagen-binding domain and an epithelial cell proliferation-modulating domain for use as tool in regenerative medicine and tissue repair |
| 12/02/2008 | US7459540 Fibroblast growth factor-like polypeptides |
| 12/02/2008 | US7459538 Recombinant tumor specific antibody and use thereof |
| 12/02/2008 | US7459537 Anti-lymphotoxin-β receptor antibodies as anti-tumor agents |
| 12/02/2008 | US7459534 Inactivation resistant factor VIII |
| 12/02/2008 | US7459533 Interleukin-10 homolog for use as a therapeutic tool in treatment and prevention of inflammatory, autoimmue and cell proliferative disorders |
| 12/02/2008 | US7459532 Transient receptor potential cation channel for use in identifying modulators for prevention and treatment of cell proliferative and nervous system disorders |
| 12/02/2008 | US7459531 Glycosylated polypeptide of given amino acid sequence; treatment of genetic diseases such as muscular dystrophy and cystic fibrosis |
| 12/02/2008 | US7459528 DNA sequences encoding tumor necrosis factor receptors; recombinant expression vectors |
| 12/02/2008 | US7459525 Glycosylated protein for use in the treatment of blood disorders |
| 12/02/2008 | US7459524 Polypeptide of given sequence; use in vaccines |
| 12/02/2008 | US7459523 Antiinflammatory ligand for use in prevention and treatment of intestinal ischemia, salmonellosis and/or sepsis |
| 12/02/2008 | US7459522 Peptide dimers as agonists of the erythropoietin (EPO) receptor, and associated methods of synthesis and use |
| 12/02/2008 | US7459442 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| 12/02/2008 | US7459441 Remedies for dry eye and diseases associated with dry eye |
| 12/02/2008 | US7459440 Ocular tear growth factor-like protein |
| 12/02/2008 | US7459439 Treating cutaneous microbial infections such as Propionibacterium acnes by administering a granulysin peptide that is modified to increase hydrophobicity |
| 12/02/2008 | US7459438 sustained relese of saratin polypeptide to prevent platelet adhesion after vascular injury; thrombosis and restenosis inhibitor |
| 12/02/2008 | US7459437 Molecular determinants of myeloma bone disease and uses thereof |
| 12/02/2008 | US7459436 Administering erythropoietin or derivative to treat diabetes |
| 12/02/2008 | US7459435 Administering erythropoietin or derivative to human suffering from diabetes |
| 12/02/2008 | US7459434 Peptide interacting with anti-apoptotic proteins of the Bcl-2 family |
| 12/02/2008 | US7459433 Lowering circulating free fatty acid levels, reducing body mass, maintaining weight loss, and treating obesity-related diseases and disorders |
| 12/02/2008 | US7459432 adminsteration of Peptide YY or an agonist to a overweight subject, or having obesity related disorders, results in decreased food intake, caloric intake, appetite, and an alteration in energy metabolism |
| 12/02/2008 | US7459431 Recombinant gelatin-like proteins for use as plasma expanders |
| 12/02/2008 | US7459430 Calcium channel modulator; delayed or sustained release |
| 12/02/2008 | US7459429 Use of erythropoietin attached to polyethylene glycol |
| 12/02/2008 | US7459428 Treating Type II diabetes comprising coadministering metformin and an inhibitor of dipeptidylpeptidase IV, especially a peptidomimetic containing a pyrrolidine ring in an amount insufficient to suppress the immune system |
| 12/02/2008 | US7459427 Reducing glucagon production by administering a corticotrophin releasing factor receptor 2 antagonist, especially a Urocortin III analog; treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety. |
| 12/02/2008 | US7459426 Methods of using IL-1 antagonists to treat autoinflammatory disease |
| 12/02/2008 | US7459425 Reagents for protection of peptide/proteins carbamylation in urea solutions utilizing non-ethylene-diamine like compounds |
| 12/02/2008 | US7459424 Peptide inhibitors of protein kinase C γ for pain management |
| 12/02/2008 | US7459300 Expression vector comprising nucleotide sequences coding metastatic tumor element for use in diagnosis, prevention and treatment of renal and cell proliferative disorders |
| 12/02/2008 | US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells |
| 12/02/2008 | US7459291 Chordin-like molecules and uses thereof |
| 12/02/2008 | US7459283 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 12/02/2008 | US7459282 Use of c-Jun or c-Jun activating agents such as UV or c-Jun N-terminal kinases (JNKs) for treating cancer |
| 12/02/2008 | US7459172 Drug encapsulation; hollow tubes; drug delivery |
| 12/02/2008 | US7459165 isolated polypeptide consisting of the amino acid sequence set forth as SEQ ID NO:4 from which the signal peptide sequence set forth as SEQ ID NO:38 is deleted; Pseudomonas aeruginosa infection |